← Leaderboards
Maria Contel
Brooklyn College
$3,930,964
Attributed
$3,930,964
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $392.5K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,930,964 · 5
By mechanism
SC1$2,972,403 · 2
R16$485,701 · 1
SC2$467,860 · 1
R13$5,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cisplatin”
- Philip J Disaia · University Of California Irvine$57,355,877
- Robert C Park · American College Of Ob And Gyn$16,339,593
- Aziz Sancar · University Of North Carolina Chapel Hill$11,887,517
- Manijeh N Goldberg · Privo Technologies, Llc$11,254,955
- Lois B. Travis · University Of Rochester$11,212,396
- Stephen J Lippard · Boston University Medical Campus$9,887,688
Research focus
CisplatinMalignant Neoplasm Of OvaryPharmaceutical PreparationsMalignant NeoplasmsGoldResistancePlatinumIn VivoIn VitroLigandsPropertyCancer Cell LineTumorMetalsPharmacologic SubstanceBaseDesignFundingChemotherapyOxaliplatinBiologicalCarboplatinGold CompoundsCytotoxic
Grant awards (15)
Platinum-Gold Compounds as Potential Chemo- and Targeted Agents for Ovarian Cancer$157,150
R16 · FY2025 · GM · contact PI
Platinum-Gold Compounds as Potential Chemo- and Targeted Agents for Ovarian Cancer$162,366
R16 · FY2024 · GM · contact PI
Platinum-Gold Compounds as Potential Chemo- and Targeted Agents for Ovarian Cancer$166,185
R16 · FY2023 · GM · contact PI
Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugs$392,500
SC1 · FY2021 · GM · contact PI
Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugs$392,500
SC1 · FY2020 · GM · contact PI
Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugs$392,500
SC1 · FY2019 · GM · contact PI
Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugs$392,500
SC1 · FY2018 · GM · contact PI
Titanium-gold-based chemotherapeutics for prostate and kidney cancer$353,250
SC1 · FY2016 · CA · contact PI
1st International Symposium on Clinical and Experimental Metallodrugs in Medicine: Cancer Chemotherapy$5,000
R13 · FY2016 · CA · contact PI
Titanium-gold-based chemotherapeutics for prostate and kidney cancer$353,250
SC1 · FY2015 · CA · contact PI
Titanium-gold-based chemotherapeutics for prostate and kidney cancer$342,653
SC1 · FY2014 · CA · contact PI
Titanium-gold-based chemotherapeutics for prostate and kidney cancer$353,250
SC1 · FY2013 · CA · contact PI
Organogold phosphorus-containing compounds as antitumor agents$155,430
SC2 · FY2012 · GM · contact PI
Organogold phosphorus-containing compounds as antitumor agents$155,430
SC2 · FY2011 · GM · contact PI
Organogold phosphorus-containing compounds as antitumor agents$157,000
SC2 · FY2010 · GM · contact PI